SCHEMBL30227920

SCHEMBL30227920

COCc1ccc2c(-c3ccccc3C)cc(=O)oc2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNA3 P22001 4/20 0.53
▸ RAB9A P51151 4/20 0.46
▸ MAOB P27338 4/20 0.46
▸ NPC1 O15118 3/20 0.46
▸ MAOA P21397 3/20 0.46
▸ CASP3 P42574 2/20 0.46
▸ SENP8 Q96LD8 2/20 0.46
▸ SENP7 Q9BQF6 2/20 0.46
▸ SENP6 Q9GZR1 2/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ CA9 Q16790 4/20 0.46
▸ CA12 O43570 3/20 0.46
▸ MEN1 O00255 3/20 0.45
▸ KMT2A Q03164 3/20 0.45
▸ HSD17B3 P37058 2/20 0.45
▸ CA1 P00915 1/20 0.43
▸ CA2 P00918 1/20 0.43
▸ CA5A P35218 1/20 0.43
▸ ALDH2 P05091 1/20 0.43
▸ AKR1B1 P15121 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30228486 0.85 KCNA3 (0.49) KCNA3RAB9AMAOBNPC1MAOA
SCHEMBL30228381 0.85 KCNA3 (0.56) KCNA3RAB9AMAOBNPC1MAOA
Hydrochloric Acid SCHEMBL30228355 0.84 KCNA3 (0.55) KCNA3RAB9AMAOBNPC1MAOA
SCHEMBL30228109 0.83 KCNA3 (0.47) KCNA3RAB9AMAOBNPC1MAOA
SCHEMBL30228517 0.83 KCNA3 (0.54) KCNA3RAB9AMAOBNPC1MAOA
SCHEMBL30228194 0.82 KCNA3 (0.48) KCNA3RAB9ACA9CA12MEN1
SCHEMBL30228231 0.82 KCNA3 (0.53) KCNA3RAB9AMAOBNPC1MAOA
SCHEMBL30228654 0.82 KCNA3 (0.44) KCNA3RAB9AMAOBNPC1MAOA
SCHEMBL31710481 0.81 KCNA3 (0.52) KCNA3RAB9AMAOBMAOATDP1
SCHEMBL30231784 0.80 KDM4E (0.67) KCNA3RAB9ANPC1MAOACASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023034346-A1 CHROMEN-2-ONE MODULATORS OF POLRMT PRETZEL THERAPEUTICS, INC. (US) 2023-03-09 — — WO disclosed
Send feedback